U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07191444) titled 'A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease' on Sept. 01.
Brief Summary: The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
Study Start Date: Sept. 18
Study Type: OBSERVATIONAL
Condition:
Still's Disease, Adult-Onset
Intervention:
BIOLOGICAL: Firsekibart
Firsekibart will be administered according to the protocol
BIOLOGICAL: Anakinra
Anakinra will be administered according to the protocol
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ruijin Hospital
Published by HT Digital Content Services with permission from Health Daily ...